Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2025-12-27 @ 6:37 AM
Study NCT ID:
NCT01163357
Status:
COMPLETED
Last Update Posted:
2025-03-26
First Post:
2010-07-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma
Sponsor:
City of Hope Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01-28
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-20
Completion Date Type:
ACTUAL
First Submit Date:
2010-07-14
First Submit QC Date:
None
Study First Post Date:
2010-07-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-24
Last Update Post Date:
2025-03-26
Last Update Post Date Type:
ACTUAL